Terms: = Liver cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
27 results:
1. A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Huang J; Cui W; Xie X; Lin K; Jin D; Xie X; Zhuang B
Int J Hyperthermia; 2023; 40(1):2256498. PubMed ID: 37733400
[TBL] [Abstract] [Full Text] [Related]
2. METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway.
Liu R; Yin G; Tuo H; Guo Y; Zhu Y; Zhang L; Yang W; Liu Q; Wang Y
Biol Direct; 2023 Sep; 18(1):53. PubMed ID: 37658413
[TBL] [Abstract] [Full Text] [Related]
3. A multicentre, multinational study of clinical characteristics and prognosis of hepatocellular carcinoma.
Dirican A; Uncu D; Sekacheva M; Artaç M; Aladashvil A; Erdogan A; Kaplan M; Alacacıoğlu A; Boukovinas I; Turhal N
East Mediterr Health J; 2023 Jun; 29(6):462-473. PubMed ID: 37551758
[TBL] [Abstract] [Full Text] [Related]
4. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
[No Abstract] [Full Text] [Related]
5. NFYAv1 is a Tumor-Promoting Transcript Associated with Poor prognosis of Hepatocellular Carcinoma.
Li Z; You C; Huang J; Zhang M
Med Sci Monit; 2023 Jan; 29():e938410. PubMed ID: 36680333
[TBL] [Abstract] [Full Text] [Related]
6. Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
Sohn W; Kang D; Kang M; Guallar E; Cho J; Paik YH
Clin Mol Hepatol; 2022 Oct; 28(4):851-863. PubMed ID: 36263667
[TBL] [Abstract] [Full Text] [Related]
7. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.
Zhang XP; Xu S; Zhao ZM; Liu Q; Zhao GD; Hu MG; Tan XL; Liu R
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):140-146. PubMed ID: 36171169
[TBL] [Abstract] [Full Text] [Related]
8. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.
Xiao Y; Zheng X; Zhou C; Huang P; Wu F; Yang C; Zeng M
Eur Radiol; 2023 Feb; 33(2):1412-1421. PubMed ID: 36112193
[TBL] [Abstract] [Full Text] [Related]
9. Current cancer burden in China: epidemiology, etiology, and prevention.
Maomao C; He L; Dianqin S; Siyi H; Xinxin Y; Fan Y; Shaoli Z; Changfa X; Lin L; Ji P; Wanqing C
Cancer Biol Med; 2022 Aug; 19(8):1121-38. PubMed ID: 36069534
[TBL] [Abstract] [Full Text] [Related]
10. miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.
Zhang Y; Yuan J; Guo M; Xiang R; Wang X; Xie T; Zhuang X; Li Q; Lai Q
Dis Markers; 2022; 2022():4842454. PubMed ID: 36033827
[TBL] [Abstract] [Full Text] [Related]
11. HFE promotes mitotic cell division through recruitment of cytokinetic abscission machinery in hepatocellular carcinoma.
Dong P; Cai Z; Li B; Zhu Y; Chan AKY; Chiang MWL; Au CH; Sung WK; Cheung TT; Lo CM; Man K; Lee NP
Oncogene; 2022 Sep; 41(36):4185-4199. PubMed ID: 35882980
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.
Xue JS; Liu H; Meng GX; Ding ZN; Yan LJ; Yao SY; Li HC; Dong ZR; Chen ZQ; Hong JG; Li T
Cancer Immunol Immunother; 2022 Jul; 71(7):1633-1644. PubMed ID: 34750662
[TBL] [Abstract] [Full Text] [Related]
13. Long-term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis.
Kumada T; Toyoda H; Yasuda S; Tada T; Ito T; Tanaka J
J Viral Hepat; 2021 Sep; 28(9):1293-1303. PubMed ID: 34185932
[TBL] [Abstract] [Full Text] [Related]
14. Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection.
Zhang L; Hu J; Hou J; Jiang X; Guo L; Tian L
Abdom Radiol (NY); 2021 Aug; 46(8):3845-3854. PubMed ID: 33733337
[TBL] [Abstract] [Full Text] [Related]
15. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract] [Full Text] [Related]
16. Identification of snoRNA SNORA71A as a Novel Biomarker in prognosis of Hepatocellular Carcinoma.
Ding Y; Sun Z; Zhang S; Zhou L; Xu Q; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
Dis Markers; 2020; 2020():8879944. PubMed ID: 33062075
[TBL] [Abstract] [Full Text] [Related]
17. Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.
Xu L; Li L; Wang P; Zhang M; Zhang Y; Hao X; Yan L; Li B; Wen T; Xu M
Gut Liver; 2019 Nov; 13(6):669-682. PubMed ID: 30970430
[TBL] [Abstract] [Full Text] [Related]
18. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
[TBL] [Abstract] [Full Text] [Related]
19. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma prognosis in a Chinese Population.
Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
[TBL] [Abstract] [Full Text] [Related]
20. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
Luo HM; Zhao SZ; Li C; Chen LP
Medicine (Baltimore); 2018 Mar; 97(12):e0226. PubMed ID: 29561452
[TBL] [Abstract] [Full Text] [Related]
[Next]
